We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+9.76%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.81B
AUM Growth
+$232M
Cap. Flow
+$110M
Cap. Flow %
6.05%
Top 10 Hldgs %
27.96%
Holding
3,974
New
205
Increased
2,252
Reduced
982
Closed
101

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$8.98M
2
NVDA icon
NVIDIA
NVDA
+$7.23M
3
MSFT icon
Microsoft
MSFT
+$5.43M
4
AMZN icon
Amazon
AMZN
+$4.83M
5
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$4.72M

Sector Composition

Rank Sector Weight
1 Technology 27.48%
2 Financials 13.08%
3 Consumer Discretionary 9.15%
4 Industrials 8.44%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLI icon
1376
RLI Corp
RLI
$5.79B
$89K ﹤0.01%
1,364
-627
-31% -$42.4K
PLMR icon
1377
Palomar
PLMR
$3.44B
$88.8K ﹤0.01%
761
-72
-9% -$9.13K
LNW
1378
DELISTED
Light & Wonder
LNW
$88.8K ﹤0.01%
1,058
-99
-9% -$9.09K
ERIE icon
1379
Erie Indemnity
ERIE
$13B
$88.8K ﹤0.01%
279
+119
+74% +$41.1K
KW
1380
DELISTED
Kennedy-Wilson Holdings
KW
$88.5K ﹤0.01%
10,636
+5,307
+100% +$42.6K
FLS icon
1381
Flowserve
FLS
$10.2B
$88.4K ﹤0.01%
1,663
+271
+19% +$14.7K
HTO
1382
H2O America
HTO
$2.57B
$88.3K ﹤0.01%
1,814
-772
-30% -$38.5K
ESGU icon
1383
iShares ESG Aware MSCI USA ETF
ESGU
$18.4B
$87.9K ﹤0.01%
604
KRYS icon
1384
Krystal Biotech
KRYS
$9.62B
$87.7K ﹤0.01%
497
+212
+74% +$31.7K
IONS icon
1385
Ionis Pharmaceuticals
IONS
$9.51B
$87.7K ﹤0.01%
1,341
+411
+44% +$20.1K
TEAM icon
1386
Atlassian
TEAM
$38.9B
$87.7K ﹤0.01%
549
-58
-10% -$10.5K
FTAI icon
1387
FTAI Aviation
FTAI
$22.3B
$87.6K ﹤0.01%
525
+97
+23% +$13.8K
CNTA
1388
DELISTED
Centessa Pharmaceuticals
CNTA
$87.6K ﹤0.01%
3,612
+421
+13% +$7.48K
NPKI
1389
NPK International
NPKI
$1.15B
$87.6K ﹤0.01%
7,742
DRH icon
1390
Diamondrock Hospitality Co
DRH
$2.47B
$87.5K ﹤0.01%
10,988
+61
+0.6% +$494
ATMU icon
1391
Atmus Filtration Technologies
ATMU
$4.1B
$87.4K ﹤0.01%
1,938
+132
+7% +$5.54K
BCPC
1392
Balchem Corp
BCPC
$5.67B
$87.3K ﹤0.01%
582
-179
-24% -$28.2K
WABC icon
1393
Westamerica Bancorp
WABC
$1.35B
$87.1K ﹤0.01%
1,743
-149
-8% -$7.38K
CRGY icon
1394
Crescent Energy
CRGY
$4.05B
$87.1K ﹤0.01%
9,760
+175
+2% +$1.59K
OII icon
1395
Oceaneering
OII
$5.03B
$86.9K ﹤0.01%
3,505
+64
+2% +$1.47K
AVTR icon
1396
Avantor
AVTR
$9.25B
$86.4K ﹤0.01%
6,924
+1,164
+20% +$15K
JAZZ icon
1397
Jazz Pharmaceuticals
JAZZ
$16.8B
$86.3K ﹤0.01%
655
+154
+31% +$18.5K
AHR icon
1398
American Healthcare REIT
AHR
$10.8B
$86.2K ﹤0.01%
2,053
+337
+20% +$13.5K
ASC icon
1399
Ardmore Shipping
ASC
$676M
$86K ﹤0.01%
7,241
+931
+15% +$10.4K
OPCH icon
1400
Option Care Health
OPCH
$3.67B
$85.9K ﹤0.01%
3,093
+600
+24% +$17.4K

Similar funds

GAMMA Investing's Q3 2025 Portfolio in Review

As of Q3 2025, GAMMA Investing held 3,974 positions worth $1.81B, up 15% from $1.58B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

GAMMA Investing deployed $110M of net new capital in Q3 2025, opening 205 new positions and adding to 2,252 existing holdings. Its largest new stake was Paramount Skydance Corp: 21,092 shares worth $399K.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Invesco CEF Income Composite ETF, an estimated $1.41M trimmed.

  • GAMMA Investing's largest Q3 2025 buy was Paramount Skydance Corp: 21,092 shares worth $399K.
  • GAMMA Investing added most to Apple in Q3 2025, an estimated $8.98M increase.
  • GAMMA Investing's biggest Q3 2025 reduction was Invesco CEF Income Composite ETF, cutting an estimated $1.41M.
  • GAMMA Investing fully exited Hess in Q3 2025, selling an estimated $1.65M.
  • GAMMA Investing's ten largest holdings make up 28% of its $1.81B portfolio in Q3 2025.
  • GAMMA Investing opened 205 new positions and closed 101 in Q3 2025.
  • GAMMA Investing's portfolio value rose 15% quarter-over-quarter to $1.81B.

Based on GAMMA Investing's 13F filing for Q3 2025, filed 2 Oct 2025.